Literature DB >> 17632711

Topiramate-induced weight loss is possibly due to the blockade of conditioned and automatic processes.

Yasser Khazaal, Daniele Fabio Zullino.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17632711     DOI: 10.1007/s00228-007-0318-0

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  10 in total

1.  The specificity of restrained versus unrestrained eaters' responses to food cues: general desire to eat, or craving for the cued food?

Authors:  Ingrid Fedoroff; Janet Polivy; C Peter Herman
Journal:  Appetite       Date:  2003-08       Impact factor: 3.868

2.  The effect of topiramate on energy balance in obese men: a 6-month double-blind randomized placebo-controlled study with a 6-month open-label extension.

Authors:  Angelo Tremblay; Jean-Philippe Chaput; Sonia Bérubé-Parent; Denis Prud'homme; Claude Leblanc; Natalie Alméras; Jean-Pierre Després
Journal:  Eur J Clin Pharmacol       Date:  2007-01-03       Impact factor: 2.953

3.  Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study.

Authors:  Pinhas N Dannon; Katherine Lowengrub; Yehudit Gonopolski; Ernest Musin; Moshe Kotler
Journal:  Clin Neuropharmacol       Date:  2005 Jan-Feb       Impact factor: 1.592

4.  Topiramate for smoking cessation.

Authors:  Yasser Khazaal; Jacques Cornuz; Romain Bilancioni; Daniele Fabio Zullino
Journal:  Psychiatry Clin Neurosci       Date:  2006-06       Impact factor: 5.188

5.  Topiramate in the long-term treatment of binge-eating disorder associated with obesity.

Authors:  Susan L McElroy; Nathan A Shapira; Lesley M Arnold; Paul E Keck; Norman R Rosenthal; Shu-Chen Wu; Julie A Capece; Lydia Fazzio; James I Hudson
Journal:  J Clin Psychiatry       Date:  2004-11       Impact factor: 4.384

6.  Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons.

Authors:  J W Gibbs; S Sombati; R J DeLorenzo; D A Coulter
Journal:  Epilepsia       Date:  2000       Impact factor: 5.864

7.  Oral topiramate for treatment of alcohol dependence: a randomised controlled trial.

Authors:  Bankole A Johnson; Nassima Ait-Daoud; Charles L Bowden; Carlo C DiClemente; John D Roache; Kevin Lawson; Martin A Javors; Jennie Z Ma
Journal:  Lancet       Date:  2003-05-17       Impact factor: 79.321

8.  A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder.

Authors:  Jose C Appolinario; Josué Bacaltchuk; Rosely Sichieri; Angelica M Claudino; Amelio Godoy-Matos; Christina Morgan; Maria T Zanella; Walmir Coutinho
Journal:  Arch Gen Psychiatry       Date:  2003-11

9.  Attenuation of cocaine-seeking behaviour by the AMPA/kainate receptor antagonist CNQX in rats.

Authors:  Pia Bäckström; Petri Hyytiä
Journal:  Psychopharmacology (Berl)       Date:  2003-01-14       Impact factor: 4.530

10.  Topiramate in the treatment of compulsive sexual behavior: case report.

Authors:  Yasser Khazaal; Daniele Fabio Zullino
Journal:  BMC Psychiatry       Date:  2006-05-23       Impact factor: 3.630

  10 in total
  3 in total

1.  Topiramate decreases the salience of motivationally relevant visual cues among smokers with alcohol use disorder.

Authors:  Jason D Robinson; Yong Cui; Maher Karam-Hage; George Kypriotakis; Francesco Versace; Nassima Ait-Daoud Tiouririne; Robert M Anthenelli; Paul M Cinciripini
Journal:  Alcohol Clin Exp Res       Date:  2022-01-31       Impact factor: 3.455

Review 2.  Antiobesity pharmacotherapy: new drugs and emerging targets.

Authors:  G W Kim; J E Lin; E S Blomain; S A Waldman
Journal:  Clin Pharmacol Ther       Date:  2013-10-08       Impact factor: 6.875

3.  Clinical utility of phentermine/topiramate (Qsymia™) combination for the treatment of obesity.

Authors:  Jin Hee Shin; Kishore M Gadde
Journal:  Diabetes Metab Syndr Obes       Date:  2013-04-08       Impact factor: 3.168

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.